JEFFS, Roger,PETERSEN, Thomas,ILAGAN, Roger M.,WADE, Michael
申请号：
AU2018201231
公开号：
AU2018201231A1
申请日:
2018.02.21
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018201231A120180315.pdf#####ABSTRACT The application is directed to a method for treating or preventing vasculopathy comprising administrating to a subject in need thereof a pharmaceutical composition comprising mesenchymal precursor cells (MPCs) and a prostacyclin. Also provided a method for treating or preventing vasculopathy in a subject in need thereof, comprising administering to the subject a prostacyclin and a mesenchymal stem cell (MSC) or a MSC-conditioned culture medium or administering to the subject a MSC or a MSC-conditioned culture medium that has treated with prostacyclin. Pharmaceutical compositions suitable for such treatments are also provided. 9995647_1 (GHMatters) P99225.AU.1
